Steven E. Nissen, MD, lead author of the study “Bempedoic Acid And Cardiovascular Outcomes In Statin-Intolerant Patients,” answers questions on the importance of his team’s research on bempedoic acid, how...
In this video, Paul M. Ridker, MD, MPH, discusses his team's recent study, which found that vascular inflammation levels in patients on statin therapy are better predictors of future cardiovascular events...
In their single-center study, Viral Shah, MD, and his research team analyzed the association between diabetes technology use and mean clinic hemoglobin A1C among adults with type 1 diabetes.
Lisa Jones, MA, RDN, LDN, discusses the ongoing egg debate, emerging research on dietary cholesterol consumption, and what dietitians and other providers can recommend to their patients.
Researcher Sara Levintow, PhD candidate, answers our questions about her research that evaluated cholesterol testing rates before and after the 2013 ACC/AHA cholesterol treatment guidelines were published....
In this video, Margo Minissian, PhD, ACNP, speaks about the new updates in cholesterol management, including the atherosclerotic cardiovascular disease risk assessment, who should get the risk assessment,...
In part 2 of our series on lipid management, Dr Paul Jellinger explains the answer to the quiz question from part 1, the AACE lipid guidelines, and the role of renal disease in managing this patient.
William E. Boden, MD, discusses his research in which he and his colleagues tried to replicate the results seen in the REDUCE-IT trial. His research was also presented at ACC.19 Scientific Session.
In this commentary, Robert Rosenson, MD, explains that PCSK9 inhibitors may be a useful alternative therapy in lowering LDL cholesterol in individuals who are unable to tolerate statins at the doses...
In this commentary, Dr Seth Martin explains the updates to the Friedewald estimation that he hopes more labs will adopt to ensure LDL assessments are as accurate as possible.
